» Articles » PMID: 25964491

Diverse Antibody Genetic and Recognition Properties Revealed Following HIV-1 Envelope Glycoprotein Immunization

Overview
Journal J Immunol
Date 2015 May 13
PMID 25964491
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

Isolation of mAbs elicited by vaccination provides opportunities to define the development of effective immunity. Ab responses elicited by current HIV-1 envelope glycoprotein (Env) immunogens display narrow neutralizing activity with limited capacity to block infection by tier 2 viruses. Intense work in the field suggests that improved Env immunogens are forthcoming, and it is therefore important to concurrently develop approaches to investigate the quality of vaccine-elicited responses at a higher level of resolution. In this study, we cloned a representative set of mAbs elicited by a model Env immunogen in rhesus macaques and comprehensively characterized their genetic and functional properties. The mAbs were genetically diverse, even within groups of Abs targeting the same subregion of Env, consistent with a highly polyclonal response. mAbs directed against two subdeterminants of Env, the CD4 binding site and V region 3, could in part account for the neutralizing activity observed in the plasma of the animal from which they were cloned, demonstrating the power of mAb isolation for a detailed understanding of the elicited response. Finally, through comparative analyses of mAb binding and neutralizing capacity of HIV-1 using matched Envs, we demonstrate complex relationships between epitope recognition and accessibility, highlighting the protective quaternary packing of the HIV-1 spike relative to vaccine-induced mAbs.

Citing Articles

HIV-1 Vpu restricts Fc-mediated effector functions in vivo.

Prevost J, Anand S, Rajashekar J, Zhu L, Richard J, Goyette G Cell Rep. 2022; 41(6):111624.

PMID: 36351384 PMC: 9703018. DOI: 10.1016/j.celrep.2022.111624.


Addressing IGHV Gene Structural Diversity Enhances Immunoglobulin Repertoire Analysis: Lessons From Rhesus Macaque.

Kaduk M, Corcoran M, Karlsson Hedestam G Front Immunol. 2022; 13:818440.

PMID: 35419009 PMC: 8995469. DOI: 10.3389/fimmu.2022.818440.


IMGT Biocuration and Analysis of the Rhesus Monkey IG Loci.

Nguefack Ngoune V, Bertignac M, Georga M, Papadaki A, Albani A, Folch G Vaccines (Basel). 2022; 10(3).

PMID: 35335026 PMC: 8950363. DOI: 10.3390/vaccines10030394.


Polyfunctional Tier 2-Neutralizing Antibodies Cloned following HIV-1 Env Macaque Immunization Mirror Native Antibodies in a Human Donor.

Spencer D, Malherbe D, Vazquez Bernat N, Adori M, Goldberg B, Dambrauskas N J Immunol. 2021; 206(5):999-1012.

PMID: 33472907 PMC: 7887735. DOI: 10.4049/jimmunol.2001082.


Extensive dissemination and intraclonal maturation of HIV Env vaccine-induced B cell responses.

Phad G, Pushparaj P, Tran K, Dubrovskaya V, Adori M, Martinez-Murillo P J Exp Med. 2019; 217(2).

PMID: 31704807 PMC: 7041718. DOI: 10.1084/jem.20191155.


References
1.
Montefiori D, Karnasuta C, Huang Y, Ahmed H, Gilbert P, de Souza M . Magnitude and breadth of the neutralizing antibody response in the RV144 and Vax003 HIV-1 vaccine efficacy trials. J Infect Dis. 2012; 206(3):431-41. PMC: 3392187. DOI: 10.1093/infdis/jis367. View

2.
Sundling C, Li Y, Huynh N, Poulsen C, Wilson R, ODell S . High-resolution definition of vaccine-elicited B cell responses against the HIV primary receptor binding site. Sci Transl Med. 2012; 4(142):142ra96. PMC: 5378478. DOI: 10.1126/scitranslmed.3003752. View

3.
Liao H, Bonsignori M, Alam S, McLellan J, Tomaras G, Moody M . Vaccine induction of antibodies against a structurally heterogeneous site of immune pressure within HIV-1 envelope protein variable regions 1 and 2. Immunity. 2013; 38(1):176-86. PMC: 3569735. DOI: 10.1016/j.immuni.2012.11.011. View

4.
Gorny M, Wang X, Williams C, Volsky B, Revesz K, Witover B . Preferential use of the VH5-51 gene segment by the human immune response to code for antibodies against the V3 domain of HIV-1. Mol Immunol. 2008; 46(5):917-26. PMC: 2693011. DOI: 10.1016/j.molimm.2008.09.005. View

5.
Sellhorn G, Kraft Z, Caldwell Z, Ellingson K, Mineart C, Seaman M . Engineering, expression, purification, and characterization of stable clade A/B recombinant soluble heterotrimeric gp140 proteins. J Virol. 2011; 86(1):128-42. PMC: 3255899. DOI: 10.1128/JVI.06363-11. View